Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures

Publisher： John Wiley & Sons Inc

E-ISSN： 1528-1167|56|7|e90-e94

ISSN： 0013-9580

Source： EPILEPSIA, Vol.56, Iss.7, 2015-07, pp. : e90-e94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long‐term safety of perampanel and seizure outcomes in refractory partial‐onset seizures and secondarily generalized seizures: Results from phase III extension study 307

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1058-1068

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial‐onset seizures: A randomized historical‐control phase III study based in North America

By  

EPILEPSIA, Vol. 56, Iss. 4, 2015-04 ,pp. : 546-555

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double‐blind, noninferiority trial

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1048-1057

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: A phase 1, randomized controlled study

By  

EPILEPSIA, Vol. 55, Iss. 12, 2014-12 ,pp. : 1934-1943

John Wiley & Sons Inc

Access to resources Recommend Favorite

Once‐daily USL255 as adjunctive treatment of partial‐onset seizures: Randomized phase III study

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1077-1087

John Wiley & Sons Inc

Access to resources Recommend Favorite